Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Blood (2009) 114 (22): 324.

https://doi.org/10.1182/blood.V114.22.324.324

Published: 2009

Journal Articles

Y-Chromosome Genes Strongly Expressed in Acute Myeloid Leukaemia.

Antonio Gallo, PhD, Dagmar Bund, PhD, Rebecca Mindnich, PhD, Raymund Buhmann, MD, Helga Schmetzer, PhD, Jerzy Adamski, PhD, Hans-Jochem Kolb, MD, PhD

Blood (2007) 110 (11): 4901.

https://doi.org/10.1182/blood.V110.11.4901.4901

Published: 2007

Journal Articles

Exogenous Nucleic Acids - A Potential Source of Resistance to Nucleoside Analogues in Cancer and Antiviral Therapy.

Raymund Buhmann, MD, Ting Yang, MD, Martin Obermeier, MD, Gundula Jaeger, MD, Hans-Jochem Kolb, MD,PhD

Blood (2007) 110 (11): 4207.

https://doi.org/10.1182/blood.V110.11.4207.4207

Published: 2007

Journal Articles

CD6-Depletion in the Dog Model: New Insights into Chimerism and Tolerance.

Julia Zorn, VMD, Martin Herber, VMD, Sabine Schwamberger, Heiko Adler, VMD, Hans-Jochem Kolb, MD, PHD

Blood (2007) 110 (11): 2173.

https://doi.org/10.1182/blood.V110.11.2173.2173

Published: 2007

Journal Articles

Host Interferon gamma Production and STAT-1 Signalling Is Crucial for Minor Antigen Mediated Rejection of High Grade Lymphoma.

Madhusudhanan Sukumar, Andrea Wilke, Eva Jaeger, Josef Mautner, PhD, Joachim Ellwart, PhD, Hans-Jochem Kolb, MD, PhD, Georg W. Bornkamm, MD, Phd, Armin Gerbitz, MD, PhD

Blood (2007) 110 (11): 2175.

https://doi.org/10.1182/blood.V110.11.2175.2175

Published: 2007

Journal Articles

Immune Effects of Imatinib in Chronic Myelogenous Leukemia In Vitro.

Dagmar Bund, PhD, Raymund Buhmann, MD, Hans-Jochem Kolb, MD, PhD

Blood (2007) 110 (11): 2956.

https://doi.org/10.1182/blood.V110.11.2956.2956

Published: 2007

Journal Articles

Polymorphism in the Promoter Region of the Hemeoxygenase I Gene of the Donor Influences Overall Survival and Graft Versus Host Disease.

Armin Gerbitz, MD, Patrick Hillemanns, Christoph Schmid, MD, Andrea Wilke, Rajshri Jayaraman, PhD, Hans-Jochem Kolb, MD, PhD, Heike Bremm, Guenther Eissner, PhD, Ernst Holler, MD, PhD

Blood (2006) 108 (11): 2879.

https://doi.org/10.1182/blood.V108.11.2879.2879

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation for MDS and sAML Following Reduced Intensity Conditioning and Preemptive Donor Lymphocyte Transfusion.

Hans-Jochem Kolb, MD, PhD, Christoph Schmid, MD, Johanna Tischer, MD, Andreas Haussmann, MD, Andreas Rank, MD, Michael Schleuning, MD, Georg Ledderose, MD

Blood (2006) 108 (11): 324.

https://doi.org/10.1182/blood.V108.11.324.324

Published: 2006

Journal Articles

Allogeneic Rejection of High Grade Lymphoma: Evidence for Immune Escape in a Haploidentical Murine Model.

Madhusudhanan Sukumar, Andrea Wilke, Josef Mautner, PhD, Hans-Jochem Kolb, MD, PhD, Georg Bornkamm, MD, PhD, Armin Gerbitz, MD

Blood (2006) 108 (11): 3171.

https://doi.org/10.1182/blood.V108.11.3171.3171

Published: 2006

Journal Articles

Single Stranded Polydeoxyribonucleotides Compete with the Incorporation of [ 3 H] Thymidine or [ 3 H]dAMP into DNA.

Ting Yang, MD, Raymund Buhmann, MD, Michaela Svihla, Hans-Jochem Kolb, MD, PhD

Blood (2005) 106 (11): 4444.

https://doi.org/10.1182/blood.V106.11.4444.4444

Published: 2005

Journal Articles

The delta Assay - A Suitable Tool To Detect the Cellular Immune Response Against Acute Myeloid Leukemia Blasts.

Sabine E. Kaiser, MD, Josef Mautner, PhD, Christoph Schmid, MD, Helga Schmetzer, PhD, Antonia Gaeta, MD, Hans-Jochem Kolb, MD, PhD

Blood (2005) 106 (11): 4563.

https://doi.org/10.1182/blood.V106.11.4563.4563

Published: 2005

Journal Articles

Risk Factors of HLA-Haploidentical Transplantation Using the Combination of Unmodified Marrow and CD6-Depleted G-CSF Mobilized Blood Cells.

Hans-Jochem Kolb, MD, PhD, Iris Bigalke, MD, Johanna Tischer, MD, Wolfgang Hill, MD, Christine Falk, PhD, Belinda Simoes, MD, Christoph Schmid, MD, Georg Ledderose, MD

Blood (2005) 106 (11): 2907.

https://doi.org/10.1182/blood.V106.11.2907.2907

Published: 2005

Journal Articles

Characterization of CD6-Negative Suppressor Cells Facilitating HLA-Haploidentical Stem Cell Transplantation.

Iris Bigalke, MD, Christine Falk, PhD, Dominik ter Meer, PhD, Marina Leeping, Dusan Prevalsek, MD, Johanna Tischer, MD, Hans-Jochem Kolb, MD, PhD

Blood (2005) 106 (11): 2909.

https://doi.org/10.1182/blood.V106.11.2909.2909

Published: 2005

Journal Articles

Adoptive Immunotherapy of p53-Mutated B-CLL with a Trifunctional Antibody (Anti-CD3 x Anti-CD20) and Allogeneic Donor Lymphocyte Transfusion.

Raymund Buhmann, MD, Michael Stanglmaier, PhD, Belinda Simoes, MD, Ting Yang, MD, Peter Ruf, PhD, Horst Lindhofer, PhD, Hans-Jochem Kolb, MD, PhD

Blood (2005) 106 (11): 4823.

https://doi.org/10.1182/blood.V106.11.4823.4823

Published: 2005

Journal Articles

Rejection of Primary Lymphoma Cells Derived from c-myc-Transgenic Mice after Haploidentical Transplantation: Treatment of the Tumor May Confer to Resistance Against GvL-Effect.

Madhusudhanan Sukumar, Andrea Wilke, Josef Mautner, PhD, Hans-Jochem Kolb, MD, PhD, Georg Bornkamm, MD, PhD, Armin Gerbitz, MD

Blood (2005) 106 (11): 5243.

https://doi.org/10.1182/blood.V106.11.5243.5243

Published: 2005

NARROW

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Y-Chromosome Genes Strongly Expressed in Acute Myeloid Leukaemia.

Exogenous Nucleic Acids - A Potential Source of Resistance to Nucleoside Analogues in Cancer and Antiviral Therapy.

CD6-Depletion in the Dog Model: New Insights into Chimerism and Tolerance.

Host Interferon gamma Production and STAT-1 Signalling Is Crucial for Minor Antigen Mediated Rejection of High Grade Lymphoma.

Immune Effects of Imatinib in Chronic Myelogenous Leukemia In Vitro.

Polymorphism in the Promoter Region of the Hemeoxygenase I Gene of the Donor Influences Overall Survival and Graft Versus Host Disease.

Allogeneic Stem Cell Transplantation for MDS and sAML Following Reduced Intensity Conditioning and Preemptive Donor Lymphocyte Transfusion.

Allogeneic Rejection of High Grade Lymphoma: Evidence for Immune Escape in a Haploidentical Murine Model.

Single Stranded Polydeoxyribonucleotides Compete with the Incorporation of [ 3 H] Thymidine or [ 3 H]dAMP into DNA.

The delta Assay - A Suitable Tool To Detect the Cellular Immune Response Against Acute Myeloid Leukemia Blasts.

Risk Factors of HLA-Haploidentical Transplantation Using the Combination of Unmodified Marrow and CD6-Depleted G-CSF Mobilized Blood Cells.

Characterization of CD6-Negative Suppressor Cells Facilitating HLA-Haploidentical Stem Cell Transplantation.

Adoptive Immunotherapy of p53-Mutated B-CLL with a Trifunctional Antibody (Anti-CD3 x Anti-CD20) and Allogeneic Donor Lymphocyte Transfusion.

Rejection of Primary Lymphoma Cells Derived from c-myc-Transgenic Mice after Haploidentical Transplantation: Treatment of the Tumor May Confer to Resistance Against GvL-Effect.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only